ResearcherUniversity Hospital OlomoucNo recent work listed
Č Neoral
Matched on ORCID iD 0000-0001-8912-8155; OpenAlex author ID A5005805075. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2013: 1 paper · 2014: none · 2015: 2 papers · 2016: 3 papers · 2017: none · 2018: none · 2019: 1 paper
Papers 7
- Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new potential hereditary genetic alteration… Co-author DOI 10.2147/cmar.s185352↗
- Long-term survival after resections for pancreatic ductal adenocarcinoma. Single centre study. Co-author DOI 10.5507/bp.2016.011↗
- [Current status regarding surgical treatment of pancreatic cancer in the Czech Republic]. Last author PMID 27226268↗
- [The survival of patients with radically non-resectable pancreatic cancer]. Co-author PMID 27410755↗
- [Determination of CEA, EGFR and hTERT expression in peritoneal lavage in patients with pancreatic adenocarcinoma using RT - PCR method]. Co-author PMID 26766154↗
- [Surgical therapy of pancreatic cancer - 5 years survival]. Co-author PMID 26766155↗
- Occult tumour cells in peritoneal lavage are a negative prognostic factor in pancreatic cancer. Co-author DOI 10.5507/bp.2012.061↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- R Havlík · 7 shared papers, 2013–2019 · strength 0.36
- Paper Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new… DOI 10.2147/cmar.s185352↗
- Paper [The survival of patients with radically non-resectable pancreatic cancer]. PMID 27410755↗
- Paper Long-term survival after resections for pancreatic ductal adenocarcinoma. Single centre study. DOI 10.5507/bp.2016.011↗
- Martin Loveček · 7 shared papers, 2013–2019 · strength 0.36
- Paper Genetic analysis of subsequent second primary malignant neoplasms in long-term pancreatic cancer survivors suggests new… DOI 10.2147/cmar.s185352↗
- Paper [The survival of patients with radically non-resectable pancreatic cancer]. PMID 27410755↗
- Paper Long-term survival after resections for pancreatic ductal adenocarcinoma. Single centre study. DOI 10.5507/bp.2016.011↗
- Dušan Klos · 5 shared papers, 2013–2016 · strength 0.24
- Paper [The survival of patients with radically non-resectable pancreatic cancer]. PMID 27410755↗
- Paper Long-term survival after resections for pancreatic ductal adenocarcinoma. Single centre study. DOI 10.5507/bp.2016.011↗
- Paper [Surgical therapy of pancreatic cancer - 5 years survival]. PMID 26766155↗
- Linda Bebarova · 3 shared papers, 2015–2016 · strength 0.16
- Paper [The survival of patients with radically non-resectable pancreatic cancer]. PMID 27410755↗
- Paper Long-term survival after resections for pancreatic ductal adenocarcinoma. Single centre study. DOI 10.5507/bp.2016.011↗
- Paper [Determination of CEA, EGFR and hTERT expression in peritoneal lavage in patients with pancreatic adenocarcinoma using … PMID 26766154↗
- Mohamed Ghothim · 3 shared papers, 2013–2015 · strength 0.13
- Paper [Surgical therapy of pancreatic cancer - 5 years survival]. PMID 26766155↗
- Paper [Determination of CEA, EGFR and hTERT expression in peritoneal lavage in patients with pancreatic adenocarcinoma using … PMID 26766154↗
- Paper Occult tumour cells in peritoneal lavage are a negative prognostic factor in pancreatic cancer. DOI 10.5507/bp.2012.061↗
- Marián Hajdúch · 2 shared papers, 2013–2015 · strength 0.08
- Marianna Borecká · 1 shared paper, 2019 · strength 0.08
- Tomáš Zemánek · 1 shared paper, 2019 · strength 0.08
- Bohuslav Melichar · 1 shared paper, 2019 · strength 0.08
- Viktor Hlaváč · 1 shared paper, 2019 · strength 0.08
- Zdeněk Kleibl · 1 shared paper, 2019 · strength 0.08
- Markéta Janatová · 1 shared paper, 2019 · strength 0.08
- Pavel Souček · 1 shared paper, 2019 · strength 0.08
- Beatrice Mohelníková-Duchoňová · 1 shared paper, 2019 · strength 0.08
- Martin Stašek · 1 shared paper, 2016 · strength 0.05
- Jan Hlavsa · 1 shared paper, 2016 · strength 0.04
- R Gürlich · 1 shared paper, 2016 · strength 0.04
- Z Krška · 1 shared paper, 2016 · strength 0.04
- Miroslav Ryska · 1 shared paper, 2016 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.